Stockreport

Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Solventum Corporation (NYSE: SOLV ) is one of the cheap new stocks to buy now . On February 26, Solventum reported Q4 2025 financial results that exceeded expectations, [Read more]